ARCHIVES

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

This article is from The Cancer Letter archive.

Vol. 07 No. 01 | January 2, 1981

Download PDF Visit The Full Archive

Related Articles

New Coalition To Lobby for Prevention

November 24, 1978

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

ASTRO Issues Statement On APBI For Breast Cancer

August 28, 2009

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

Drug Development Committee Demands, Gets Greater Voice In Contract Awards, Review of Unsolicited Proposals, Suggests RFP For New Screening Systems

January 2, 1976